Proactiveinvestors Australia Abbott Laboratories https://www.proactiveinvestors.com.au Proactiveinvestors Australia Abbott Laboratories RSS feed en Mon, 18 Nov 2019 12:59:33 +1100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Abbott Laboratories posts higher-than-estimated 1Q profit on diagnostics business https://www.proactiveinvestors.com.au/companies/news/195262/abbott-laboratories-posts-higher-than-estimated-1q-profit-on-diagnostics-business-195262.html Wed, 18 Apr 2018 12:21:00 +1000 https://www.proactiveinvestors.com.au/companies/news/195262/abbott-laboratories-posts-higher-than-estimated-1q-profit-on-diagnostics-business-195262.html Abbott Labs reports solid fourth quarter earnings, although headline numbers hit by US tax changes https://www.proactiveinvestors.com.au/companies/news/190566/abbott-labs-reports-solid-fourth-quarter-earnings-although-headline-numbers-hit-by-us-tax-changes-190566.html Wed, 24 Jan 2018 15:29:00 +1100 https://www.proactiveinvestors.com.au/companies/news/190566/abbott-labs-reports-solid-fourth-quarter-earnings-although-headline-numbers-hit-by-us-tax-changes-190566.html Abbott Laboratories denies it is eyeing St Jude https://www.proactiveinvestors.com.au/companies/news/114362/abbott-laboratories-denies-it-is-eyeing-st-jude-114362.html Thu, 27 Aug 2015 17:24:00 +1000 https://www.proactiveinvestors.com.au/companies/news/114362/abbott-laboratories-denies-it-is-eyeing-st-jude-114362.html Abbott Laboratories' second quarter revenue, net income rise https://www.proactiveinvestors.com.au/companies/news/96296/abbott-laboratories-second-quarter-revenue-net-income-rise-46158.html Wed, 17 Jul 2013 14:46:00 +1000 https://www.proactiveinvestors.com.au/companies/news/96296/abbott-laboratories-second-quarter-revenue-net-income-rise-46158.html Abbott Laboratories posts 56% drop in Q1 profit, backs FY forecast https://www.proactiveinvestors.com.au/companies/news/94346/abbott-laboratories-posts-56-drop-in-q1-profit-backs-fy-forecast-42833.html Wed, 17 Apr 2013 13:53:00 +1000 https://www.proactiveinvestors.com.au/companies/news/94346/abbott-laboratories-posts-56-drop-in-q1-profit-backs-fy-forecast-42833.html Abbott FY outlook tops views, but shares slide as Q4 profit falls 35% https://www.proactiveinvestors.com.au/companies/news/92575/abbott-fy-outlook-tops-views-but-shares-slide-as-q4-profit-falls-35-39727.html Wed, 23 Jan 2013 14:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/92575/abbott-fy-outlook-tops-views-but-shares-slide-as-q4-profit-falls-35-39727.html Abbott Labratories narrows FY EPS guidance range, shares fall https://www.proactiveinvestors.com.au/companies/news/90472/abbott-labratories-narrows-fy-eps-guidance-range-shares-fall-36107.html Wed, 17 Oct 2012 14:50:00 +1100 https://www.proactiveinvestors.com.au/companies/news/90472/abbott-labratories-narrows-fy-eps-guidance-range-shares-fall-36107.html Abbott Laboratories Q2 profit down 11%, reaffirms full year forecast https://www.proactiveinvestors.com.au/companies/news/88002/abbott-laboratories-q2-profit-down-11-reaffirms-full-year-forecast-32136.html Wed, 18 Jul 2012 16:55:00 +1000 https://www.proactiveinvestors.com.au/companies/news/88002/abbott-laboratories-q2-profit-down-11-reaffirms-full-year-forecast-32136.html Abbott inks alliance with Galapagos to make, sell arthritis drug https://www.proactiveinvestors.com.au/companies/news/84119/abbott-inks-alliance-with-galapagos-to-make-sell-arthritis-drug-25606.html Wed, 29 Feb 2012 16:23:00 +1100 https://www.proactiveinvestors.com.au/companies/news/84119/abbott-inks-alliance-with-galapagos-to-make-sell-arthritis-drug-25606.html Abbott Labs Q4 profits rise, though sales miss Street view https://www.proactiveinvestors.com.au/companies/news/83128/abbott-labs-q4-profits-rise-though-sales-miss-street-view-24015.html Wed, 25 Jan 2012 17:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/83128/abbott-labs-q4-profits-rise-though-sales-miss-street-view-24015.html Abbot Labs to split into two, Q3 earnings down 66% on legal charge https://www.proactiveinvestors.com.au/companies/news/80685/abbot-labs-to-split-into-two-q3-earnings-down-66-on-legal-charge-19868.html Wed, 19 Oct 2011 14:04:00 +1100 https://www.proactiveinvestors.com.au/companies/news/80685/abbot-labs-to-split-into-two-q3-earnings-down-66-on-legal-charge-19868.html Abbott's FISH test for Leukemia cleared by FDA https://www.proactiveinvestors.com.au/companies/news/79296/abbotts-fish-test-for-leukemia-cleared-by-fda-17469.html Mon, 22 Aug 2011 16:24:00 +1000 https://www.proactiveinvestors.com.au/companies/news/79296/abbotts-fish-test-for-leukemia-cleared-by-fda-17469.html Abbott posts 50% Q2 profit growth, revenues rise on pharmaceuticals https://www.proactiveinvestors.com.au/companies/news/78734/abbott-posts-50-q2-profit-growth-revenues-rise-on-pharmaceuticals-16490.html Wed, 20 Jul 2011 15:39:00 +1000 https://www.proactiveinvestors.com.au/companies/news/78734/abbott-posts-50-q2-profit-growth-revenues-rise-on-pharmaceuticals-16490.html Abbott and Biotest sign development deal for immune disease drug https://www.proactiveinvestors.com.au/companies/news/78204/abbott-and-biotest-sign-development-deal-for-immune-disease-drug-15634.html Tue, 21 Jun 2011 19:12:00 +1000 https://www.proactiveinvestors.com.au/companies/news/78204/abbott-and-biotest-sign-development-deal-for-immune-disease-drug-15634.html Abbott receives CE Mark approval for coronary artery disease treatment https://www.proactiveinvestors.com.au/companies/news/75630/abbott-receives-ce-mark-approval-for-coronary-artery-disease-treatment-11295.html Mon, 10 Jan 2011 19:31:00 +1100 https://www.proactiveinvestors.com.au/companies/news/75630/abbott-receives-ce-mark-approval-for-coronary-artery-disease-treatment-11295.html Abbott Laboratories and Health Canada take weight-loss drug Meridia off the Canadian market https://www.proactiveinvestors.com.au/companies/news/74231/-abbott-laboratories-and-health-canada-take-weight-loss-drug-meridia-off-the-canadian-market-9073.html Fri, 08 Oct 2010 21:51:00 +1100 https://www.proactiveinvestors.com.au/companies/news/74231/-abbott-laboratories-and-health-canada-take-weight-loss-drug-meridia-off-the-canadian-market-9073.html